Home
Atlas Venture Fund XI, 10% Owner: Dyne Therapeutics DYN Sell · Filed 24/02/23
Trade details
- Type
- Insider sale
- Amount
- $3,621,603.4
- Shares · price
- 159,542 sh · $22.70 a share
- Held after
- 6,352,562 sh
- Trade date
- 24/02/23
- Filed
- 24/02/23
- Days to filing
- 0 days
Sold 2.4% of holdings
- Share of holding sold
- 2.4%
Dyne Therapeutics trades, last 26 weeks
What else happened in Dyne Therapeutics around then
Filed or reported within 30 days of the trade day · 24/01/24~24/03/24Atlas Venture Fund XI's recent trades
- Atlas Venture Fund XI
Planned sale10b5-1 planKorro Bio
Planned sale10b5-1 planKorro Bio
KRRO
$440.4K
31,888 sh
$440.4K
Filed 09/14
Traded 09/14
- Atlas Venture Fund XI
Planned sale10b5-1 planKorro Bio
Planned sale10b5-1 planKorro Bio
KRRO
$110.4K
8,450 sh
$110.4K
Filed 09/11
Traded 09/11
- Atlas Venture Fund XI
Planned sale10b5-1 planKorro Bio
Planned sale10b5-1 planKorro Bio
KRRO
$3,419
249 sh
$3,419
Filed 08/26
Traded 08/26
- Atlas Venture Fund XI
Planned sale10b5-1 planKorro Bio
Planned sale10b5-1 planKorro Bio
KRRO
$311.8K
23,584 sh
$311.8K
Filed 08/19
Traded 08/19
- Atlas Venture Fund XI
Planned sale10b5-1 planDyne Therapeutics
Planned sale10b5-1 planDyne Therapeutics
DYN
$35.3M
1,359,674 sh
$35.3M
Filed 08/14
Traded 08/14